The FDA has granted Dexcel Pharma Technologies Ltd. approval to market omeprazole, a generic version of AstraZeneca PLC's heartburn drug Prilosec, for use without prescription. Perrigo Co., Dexcel's partner in marketing the drug, said the over-the-counter tablets may be launched in the U.S. in the first quarter of 2008.

Full Story:

Related Summaries